120 related articles for article (PubMed ID: 20845657)
1. What is MRSA?
Hewett ML
JAAPA; 2010 Sep; 23(9):59. PubMed ID: 20845657
[No Abstract] [Full Text] [Related]
2. Community-acquired methicillin-resistant Staphylococcus aureus and Lemierre syndrome.
Bilal M; Cleveland KO; Gelfand MS
Am J Med Sci; 2009 Oct; 338(4):326-7. PubMed ID: 19701080
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory, anti-coagulant, anti-biotic?
Herwald H
Thromb Haemost; 2013 Apr; 109(4):582. PubMed ID: 23407848
[No Abstract] [Full Text] [Related]
4. In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.
Guo Y; Ramos RI; Cho JS; Donegan NP; Cheung AL; Miller LS
Antimicrob Agents Chemother; 2013 Feb; 57(2):855-63. PubMed ID: 23208713
[TBL] [Abstract][Full Text] [Related]
5. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Puzniak LA; Morrow LE; Huang DB; Barreto JN
Clin Ther; 2013 Oct; 35(10):1557-70. PubMed ID: 24011955
[TBL] [Abstract][Full Text] [Related]
6. Management of methicillin-resistant Staphylococcus aureus pneumonia.
Luna CM; Boyeras Navarro ID
Curr Opin Infect Dis; 2010 Apr; 23(2):178-84. PubMed ID: 20075728
[TBL] [Abstract][Full Text] [Related]
7. Linezolid and clindamycin improve the outcome of severe, necrotizing pneumonia due to community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).
Soavi L; Signorini L; Stellini R; Acquarolo A; Fiorese B; Magri S; Pantosti A; Suter F; Carori G
Infez Med; 2011 Mar; 19(1):42-4. PubMed ID: 21471746
[TBL] [Abstract][Full Text] [Related]
8. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.
Wunderink RG; Niederman MS; Kollef MH; Shorr AF; Kunkel MJ; Baruch A; McGee WT; Reisman A; Chastre J
Clin Infect Dis; 2012 Mar; 54(5):621-9. PubMed ID: 22247123
[TBL] [Abstract][Full Text] [Related]
9. Community-acquired methicillin-resistant Staphylococcus aureus meningitis complicated by cerebral infarction. Role of antibiotic combination of linezolid plus levofloxacin.
Fernández-Ruiz M; Cervera C; Pitart C; Pérez G; del Río A; Miró JM; Marco F; Moreno A
Intern Med; 2010; 49(18):1971-4. PubMed ID: 20847500
[TBL] [Abstract][Full Text] [Related]
10. Improved antimicrobial activity of linezolid against vancomycin-intermediate Staphylococcus aureus.
Watanabe Y; Neoh HM; Cui L; Hiramatsu K
Antimicrob Agents Chemother; 2008 Nov; 52(11):4207-8. PubMed ID: 18710909
[No Abstract] [Full Text] [Related]
11. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
12. Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid.
Kessler AT; Kourtis AP
Infection; 2007 Jun; 35(4):271-4. PubMed ID: 17646913
[TBL] [Abstract][Full Text] [Related]
13. [The cutting-edge of medicine anti-MRSA agents; how to select and how to use].
Niki Y
Nihon Naika Gakkai Zasshi; 2012 Apr; 101(4):1085-91. PubMed ID: 22730740
[No Abstract] [Full Text] [Related]
14. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
Itani KM; Biswas P; Reisman A; Bhattacharyya H; Baruch AM
Clin Ther; 2012 Aug; 34(8):1667-73.e1. PubMed ID: 22770644
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of disseminated cerebritis complicating methicillin-resistant Staphylococcus aureus Endocarditis unresponsive to vancomycin therapy with linezolid.
Pistella E; Campanile F; Bongiorno D; Stefani S; Di Nucci GD; Serra P; Venditti M
Scand J Infect Dis; 2004; 36(3):222-5. PubMed ID: 15119370
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus.
Docobo-Pérez F; López-Rojas R; Domínguez-Herrera J; Jiménez-Mejias ME; Pichardo C; Ibáñez-Martínez J; Pachón J
J Antimicrob Chemother; 2012 Aug; 67(8):1961-7. PubMed ID: 22532466
[TBL] [Abstract][Full Text] [Related]
17. Preseptal cellulitis caused by community acquired methicillin resistant Staphylococcus aureus (CAMRSA).
Charalampidou S; Connell P; Fennell J; Lynch M; Acheson R
Br J Ophthalmol; 2007 Dec; 91(12):1723-4. PubMed ID: 18024828
[No Abstract] [Full Text] [Related]
18. Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
Segarra-Newnham M; Church TJ
Ann Pharmacother; 2012 Dec; 46(12):1678-87. PubMed ID: 23232021
[TBL] [Abstract][Full Text] [Related]
19. Methicillin-resistant Staphylococcus aureus-induced thrombo-inflammatory response is reduced with timely antibiotic administration.
Franks Z; Campbell RA; Vieira de Abreu A; Holloway JT; Marvin JE; Kraemer BF; Zimmerman GA; Weyrich AS; Rondina MT
Thromb Haemost; 2013 Apr; 109(4):684-95. PubMed ID: 23348831
[TBL] [Abstract][Full Text] [Related]
20. Pneumonia caused by methicillin-resistant Staphylococcus aureus.
Rubinstein E; Kollef MH; Nathwani D
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S378-85. PubMed ID: 18462093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
